Junior Lozo 15 Orange Tablet MD contains Lansoprazole 15 mg, a proton pump inhibitor indicated for the treatment of acid-related gastrointestinal conditions in pediatric patients. Lansoprazole acts by selectively inhibiting the H+/K+ ATPase enzyme system at the secretory surface of gastric parietal cells, thereby suppressing gastric acid secretion. This reduction in gastric acidity promotes healing of erosive esophagitis, gastroesophageal reflux disease (GERD), and peptic ulcers, and provides symptomatic relief from heartburn and acid indigestion. Junior Lozo 15 Orange Tablet MD is specifically formulated for children requiring acid suppression therapy, ensuring appropriate dosing and palatability. The orange-flavored tablet facilitates ease of administration in the pediatric population. It is recommended to be taken orally, preferably before meals, to maximize therapeutic efficacy. Common adverse effects may include headache, abdominal pain, nausea, and diarrhea, though these are generally mild and transient. Caution is advised in patients with known hypersensitivity to Lansoprazole or other proton pump inhibitors. Use during pregnancy and lactation should be under medical supervision. Junior Lozo 15 Orange Tablet MD should be used as directed by a healthcare professional, with adherence to prescribed dosage and duration to ensure optimal clinical outcomes and minimize potential risks.